# World-wide Randomized Antibiotic Envelope Infection Prevention Trial

> **NCT02277990** · PHASE4 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 7075 (actual)

## Conditions studied

- CIED Related Infection

## Interventions

- **DEVICE:** TYRX™ Absorbable Antibacterial Envelope

## Key facts

- **NCT ID:** NCT02277990
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 7075 (ACTUAL)
- **Last updated:** 2019-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02277990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02277990, "World-wide Randomized Antibiotic Envelope Infection Prevention Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02277990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*